Literature DB >> 4041797

Time-course and regional distribution of the metabolic effects of bromocriptine in the rat brain.

G Pizzolato, T T Soncrant, S I Rapoport.   

Abstract

Local cerebral glucose utilization (LCGU) and motor behavior were examined in awake Fischer-344 rats after administration of the dopaminergic agonist bromocriptine (BROMO). LCGU was measured using the [14C]2-deoxyglucose technique in 63 brain regions at 1,2,3 or 4 h after BROMO 20 mg/kg, and at 4 h after BROMO 100 mg/kg i.p. At 2 h, LCGU was reduced significantly in 13% of the 63 regions examined. The affected regions are related to the topographical distribution of dopaminergic innervation in the brain. At 3-4 h, LCGU remained depressed in some of the above dopaminergic regions, but was elevated significantly in regions which are involved in sensorimotor function. BROMO also produced two behavioral effects depending on time after administration. Locomotor activity was depressed at 1-2 h, and stereotyped behavior appeared at 3-4 h. The time-dependent effects of BROMO may reflect progressively increasing brain concentrations of the drug or of its active metabolites. The coincidence of locomotor depression and reduction of LCGU in dopaminergic regions suggests a role of dopamine autoreceptors in regulation of motor function. Metabolic stimulation of many non-dopaminergic regions when stereotypy is evident suggests that circuit(s) involving these areas may contribute to stereotypy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4041797     DOI: 10.1016/0006-8993(85)91069-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Dopaminergic challenge with bromocriptine one month after mild traumatic brain injury: altered working memory and BOLD response.

Authors:  Thomas W McAllister; Laura A Flashman; Brenna C McDonald; Richard B Ferrell; Tor D Tosteson; Norman N Yanofsky; Margaret R Grove; Andrew J Saykin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

2.  Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI.

Authors:  D Y Kimberg; G K Aguirre; J Lease; M D'Esposito
Journal:  Hum Brain Mapp       Date:  2001-04       Impact factor: 5.038

3.  Chronic lithium chloride administration to rats elevates glucose metabolism in wide areas of brain, while potentiating negative effects on metabolism of dopamine D2-like receptor stimulation.

Authors:  Mireille Basselin; Lisa Chang; Stanley I Rapoport
Journal:  Psychopharmacology (Berl)       Date:  2006-06-20       Impact factor: 4.530

4.  Dopamine D2 Receptor Signaling in the Nucleus Accumbens Comprises a Metabolic-Cognitive Brain Interface Regulating Metabolic Components of Glucose Reinforcement.

Authors:  Michael Michaelides; Michael L Miller; Jennifer A DiNieri; Juan L Gomez; Elizabeth Schwartz; Gabor Egervari; Gene Jack Wang; Charles V Mobbs; Nora D Volkow; Yasmin L Hurd
Journal:  Neuropsychopharmacology       Date:  2017-06-05       Impact factor: 7.853

5.  The Acute Pharmacological Manipulation of Dopamine Receptors Modulates Judgment Bias in Japanese Quail.

Authors:  Katarína Pichová; Ľubica Kubíková; Ľubor Košťál
Journal:  Front Physiol       Date:  2022-05-11       Impact factor: 4.755

6.  Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.

Authors:  U Freo; H W Holloway; N H Greig; T T Soncrant
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  PET measurement of dopamine D2 receptor-mediated changes in striatopallidal function.

Authors:  K J Black; M H Gado; J S Perlmutter
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

8.  Methiothepin reduces glucose utilization in forebrain regions of awake rats.

Authors:  G L Ricchieri; T T Soncrant; H W Holloway; S I Rapoport
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

9.  Spontaneous Eye Blink Rate (EBR) Is Uncorrelated with Dopamine D2 Receptor Availability and Unmodulated by Dopamine Agonism in Healthy Adults.

Authors:  Linh C Dang; Gregory R Samanez-Larkin; Jaime J Castrellon; Scott F Perkins; Ronald L Cowan; Paul A Newhouse; David H Zald
Journal:  eNeuro       Date:  2017-09-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.